Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
American Shared Hospital Service (AMS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/20/2025: AMS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -24.54% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.75M USD | Price to earnings Ratio 11.63 | 1Y Target Price 4.85 |
Price to earnings Ratio 11.63 | 1Y Target Price 4.85 | ||
Volume (30-day avg) - | Beta 0.29 | 52 Weeks Range 2.30 - 4.60 | Updated Date 06/29/2025 |
52 Weeks Range 2.30 - 4.60 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.21 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.93% | Operating Margin (TTM) -14.17% |
Management Effectiveness
Return on Assets (TTM) 0.71% | Return on Equity (TTM) 2% |
Valuation
Trailing PE 11.63 | Forward PE 7.58 | Enterprise Value 32553125 | Price to Sales(TTM) 0.54 |
Enterprise Value 32553125 | Price to Sales(TTM) 0.54 | ||
Enterprise Value to Revenue 1.11 | Enterprise Value to EBITDA 4.15 | Shares Outstanding 6450000 | Shares Floating 3419790 |
Shares Outstanding 6450000 | Shares Floating 3419790 | ||
Percent Insiders 49.7 | Percent Institutions 13.91 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
American Shared Hospital Service
Company Overview
History and Background
American Shared Hospital Services (AMS) was founded in 1980. It is a provider of stereotactic radiosurgery and advanced radiation therapy equipment. The company leases medical equipment to hospitals and medical centers.
Core Business Areas
- Stereotactic Radiosurgery (SRS) and Radiation Therapy: AMS provides Gamma Knife and LINAC-based stereotactic radiosurgery and radiation therapy equipment, along with related services.
Leadership and Structure
The leadership team includes the CEO, CFO, and other key executives. The organizational structure is typical of a small publicly traded company with functional departments.
Top Products and Market Share
Key Offerings
- Gamma Knife Radiosurgery: AMS offers Gamma Knife radiosurgery equipment and services. Market share data is not readily available. Competitors include Elekta (offers competing Leksell Gamma Knife systems), Varian Medical Systems (now Siemens Healthineers, offers linear accelerators for radiosurgery).
- Market Share: Not readily available publicly. AMS does not provide market share data.
- LINAC-based Radiosurgery: AMS leases LINAC (Linear Accelerator) equipment for radiation therapy and radiosurgery. Competitors include Varian Medical Systems (now Siemens Healthineers), Accuray Incorporated (ARAY).
Market Dynamics
Industry Overview
The market involves medical equipment leasing and specialized radiation therapy services. Demand is driven by cancer incidence, technological advancements, and hospital budgets.
Positioning
AMS is a niche player specializing in Gamma Knife and LINAC-based radiosurgery equipment leasing. Its competitive advantage lies in providing access to advanced technology without large capital expenditures for hospitals.
Total Addressable Market (TAM)
The TAM for stereotactic radiosurgery and advanced radiation therapy is estimated to be in the billions of dollars globally. AMS is positioned to capture a small portion of this TAM by offering equipment leasing and related services. Exact TAM figures are difficult to obtain.
Upturn SWOT Analysis
Strengths
- Specialized niche focus
- Long-term contracts
- Established relationships with hospitals
- Experienced management team
Weaknesses
- Small market capitalization
- Dependence on a limited number of equipment types
- Sensitivity to changes in healthcare regulations
- Limited diversification
- High Debt to Equity
Opportunities
- Expanding into new geographic markets
- Adopting new technologies
- Increasing demand for radiosurgery
- Strategic acquisitions
- Growth of AI in Radiology
Threats
- Competition from larger medical equipment companies
- Changes in reimbursement policies
- Economic downturns affecting hospital budgets
- Technological obsolescence
- Alternative treatments
Competitors and Market Share
Key Competitors
- SIEMENS HEALTHINEERS (SEMHF)
- ELEKTA AB (EKTAY)
- Accuray Incorporated (ARAY)
Competitive Landscape
AMS faces strong competition from larger, more diversified medical equipment companies. Its advantage lies in its specialized focus and leasing model. AMS is much smaller than its main competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been modest, with fluctuations based on equipment installations and contract renewals.
Future Projections: Future growth projections are not readily available. Analyst estimates would be required.
Recent Initiatives: Recent initiatives may include new equipment installations, contract renewals, and expansion into new markets.
Summary
American Shared Hospital Services is a niche player in the stereotactic radiosurgery equipment leasing market. The company's strength lies in its specialized focus and long-term contracts. The small size of AMS makes them more susceptible to bigger competitors and overall revenue is low compared to its peers.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Financial news sources
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market share data is estimated and may not be precise. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Shared Hospital Service
Exchange NYSE MKT | Headquaters San Francisco, CA, United States | ||
IPO Launch date 1984-09-07 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 81 | Website https://ashs.com |
Full time employees 81 | Website https://ashs.com | ||
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments, Leasing and Retail. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.